Research and Markets has announced the addition of the "US Hyperphosphataemia Market and Competitive Landscape Highlights - 2016" drug pipelines to their offering.
US Hyperphosphataemia Market and Competitive Landscape Highlights - 2016, provides comprehensive insights into Hyperphosphataemia pipeline products, Hyperphosphataemia epidemiology, Hyperphosphataemia market valuations and forecast, Hyperphosphataemia products sales and competitive landscape in the US.
The research is classified into nine sections - Hyperphosphataemia overview including etiology, pathophysiology, and diagnosis, Hyperphosphataemia treatment options, Hyperphosphataemia pipeline products, Hyperphosphataemia market analysis comprising of Hyperphosphataemia epidemiology, key products marketed for Hyperphosphataemia, market valuations and forecast, products sales and market shares.
Key Topics Covered:
For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/w4fmxg/us
View source version on businesswire.com: http://www.businesswire.com/news/home/20161005005803/en/Business Wire
Last updated on: 05/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.